<H1>Chapter DOI: 10.1208/aapsj070356<br/>Cited-By Count: 16</H1><table border="1" width="30%"><tr><td>Total References</td><td>43</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>42</td></tr><tr><td>BibStructured Count</td><td width="10%">43</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>31</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by kappa opiate receptors.<Emphasis Type="Italic">Science</Emphasis>. 1986;233:774&#8211;776.</td><td><a href=http://dx.doi.org/10.1126/science.3016896>10.1126/science.3016896</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Walsh SL, Strain EC, Abreu ME, Bigelow GE. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2001;157:151&#8211;162.</td><td><a href=http://dx.doi.org/10.1007/s002130100788>10.1007/s002130100788</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Yaksh TL. In vivo studies on spinal opiate receptor systems mediating antinociception, I: mu and delta receptor profiles in the primate.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1983;226:303&#8211;316.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1984;230:341&#8211;348.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F. Direct dependence studies in rats with agents selective for different types of opioid receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1988;246:950&#8211;955.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Cheng PY, Wu D, Decena J, Soong Y, McCabe S, Szeto HH. Opioid-induced stimulation of fetal respiratory activity by [D-Ala<Superscript>2</Superscript>]deltorphin, I.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1993;230:85&#8211;88.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(93)90413-C>10.1016/0014-2999(93)90413-C</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Galligan JJ, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1984;229:641&#8211;648.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Weber SJ, Greene DL, Sharma SD, et al. Distribution and analgesia of [<Superscript>3</Superscript>H][D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]enkephalin and two halogenated analogs after intravenous administration.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1991;259:1109&#8211;1117.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Svensson CI, Rew Y, Malkmus S, et al. Systemic and spinal analgesic activity of a &#948;-opioid-selective lanthionine enkephalin analog.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:827&#8211;832.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.039750>10.1124/jpet.102.039750</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Kamei J, Saitoh A, Ohsawa M, et al. Antinociceptive effects of the selective non-peptidic &#948;-opioid receptor antagonist TAN-67 in diabetic mice.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1995;276:131&#8211;135.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(95)00026-H>10.1016/0014-2999(95)00026-H</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Chang K-J, Rigdon GC, Howard JL, McNutt RW. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1993;267:852&#8211;857.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Calderon SN, Rothman RB, Porreca F, et al. Probes for narcotic receptor mediated phenomena, 19: synthesis of (+)-4-(&#945;R)-&#945;-((2S, 5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80): a highly selective, nonpeptide delta opioid receptor agonist.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1994;37:2125&#8211;2128.</td><td><a href=http://dx.doi.org/10.1021/jm00040a002>10.1021/jm00040a002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Plobeck N, Delorme D, Wei Z-Y, et al. New diarylmethylpiperazines as potent and selective nonpeptidic &#948; opioid receptor agonists with increased in vitro metabolic stability.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2000;43:3878&#8211;3894.</td><td><a href=http://dx.doi.org/10.1021/jm000228x>10.1021/jm000228x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>DeHaven-Hudkins DL, Dolle RE. Peripherally restricted opioid agonists as novel analgesic agents.<Emphasis Type="Italic">Curr Pharm Des</Emphasis>. 2004;10:743&#8211;757.</td><td><a href=http://dx.doi.org/10.2174/1381612043453036>10.2174/1381612043453036</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Schiller PW, Nguyen TM-D, Chung NN, Lemieux C. Dermorphin analogues carrying an increased positive net charge in their &#8220;message&#8221; domain display extremely high &#956;-opioid receptor selectivity.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1989;32:698&#8211;703.</td><td><a href=http://dx.doi.org/10.1021/jm00123a035>10.1021/jm00123a035</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Schiller PW, Nguyen TM-D, Berezowska I, et al. Synthesis and in vitro opioid activity profiles of DALDA analogues.<Emphasis Type="Italic">Eur J Med Chem</Emphasis>. 2000;35:895&#8211;901.</td><td><a href=http://dx.doi.org/10.1016/S0223-5234(00)01171-5>10.1016/S0223-5234(00)01171-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Neilan CL, Nguyen TM-D, Schiller PW, Pasternak GW. Pharmacological characterization of the dermorphim analog [Dmt<Superscript>1</Superscript>]DALDA, a highly potent and selective &#956;-opioid peptide.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2001;419:15&#8211;23.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(01)00946-3>10.1016/S0014-2999(01)00946-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Neilan CL, Janvey AJ, Bolan E, et al. Characterization of the binding of [<Superscript>3</Superscript>H][Dmt<Superscript>1</Superscript>]H-Dmt-D-Arg-Phe-Lys-NH<Subscript>2</Subscript>, a highly potent opioid peptide.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;306:430&#8211;436.</td><td><a href=http://dx.doi.org/10.1124/jpet.103.049742>10.1124/jpet.103.049742</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Szeto HH, Lovelace JL, Fridland G, et al. In vivo pharmacokinetics of selective &#956;-opioid peptide agonists.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:57&#8211;61.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Shimoyama M, Shimoyama N, Zhao G-M, Schiller PW, Szeto HH. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH<Subscript>2</Subscript> (DALDA) and [Dmt<Superscript>1</Superscript>]DALDA.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;297:364&#8211;371.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Reimann W, Schlutz H, Selve N. The antinociceptive effects of morphine, desipramine, and serotonin and their combinations after intrathecal injection in the rat.<Emphasis Type="Italic">Anesth Analg</Emphasis>. 1999;88:141&#8211;145.</td><td><a href=http://dx.doi.org/10.1097/00000539-199901000-00026>10.1097/00000539-199901000-00026</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Szeto HH, Soong Y, Wu D, Qian X, Zhao G-M. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt<Superscript>1</Superscript>]DALDA.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;305:696&#8211;702.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.048561>10.1124/jpet.102.048561</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Zhao GM, Wu D, Soong Y, et al. Profound spinal tolerance after repeated exposure to a highly selective &#956;-opioid peptide agonist: role of &#948;-opioid receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2002;302:188&#8211;196.</td><td><a href=http://dx.doi.org/10.1124/jpet.302.1.188>10.1124/jpet.302.1.188</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Ben Y, Smith AP, Schiller PW, Lee NM. Tolerance develops in spinal cord, but not in brain with chronic [Dmt<Superscript>1</Superscript>]DALDA treatment.<Emphasis Type="Italic">Br J Pharmacol.</Emphasis> 2004;143:987&#8211;993.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0706007>10.1038/sj.bjp.0706007</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Neilan CL, King MA, Rossi G, et al. Differential sensitivities of mouse strains to morphine and [Dmt<Superscript>1</Superscript>]DALDA analgesia.<Emphasis Type="Italic">Brain Res</Emphasis>. 2003;974:254&#8211;257.</td><td><a href=http://dx.doi.org/10.1016/S0006-8993(03)02590-3>10.1016/S0006-8993(03)02590-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Riba P, Ben Y, Nguyen TM-D, Furst S, Schiller PW, Lee NM. [Dmt<Superscript>1</Superscript>]DALDA is highly selective and potent at &#956; opioid receptors, but is not cross-tolerant with systemic morphine.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 2002;9:31&#8211;39.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Zhao K, Luo G, Zhao G-M, Schiller PW, Szeto HH. Transcellular transport of a highly polar 3+net charge opioid tetrapeptide.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:425&#8211;432.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.040147>10.1124/jpet.102.040147</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Berezowska I, Chung NN, Lemieux C, Zelent B, Szeto HH, Schiller PW. Highly potent fluorescent analogues of the opioid peptide [Dmt<Superscript>1</Superscript>]DALDA.<Emphasis Type="Italic">Peptides</Emphasis>. 2003;24:1195&#8211;1200.</td><td><a href=http://dx.doi.org/10.1016/j.peptides.2003.07.004>10.1016/j.peptides.2003.07.004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1991;258:299&#8211;303.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Fundytus ME, Schiller PW, Shapiro M, Weltrowska G, Coderre TJ. The highly selective &#948;-opioid antagonist H-Tyr-Tic&#966;[CH<Subscript>2</Subscript>-NH]Phe-Phe-OH (TIPP[&#966;]) attenuates morphine tolerance and dependence.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1995;286:105&#8211;108.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(95)00554-X>10.1016/0014-2999(95)00554-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Rothman RB, Danks JA, Jacobson AE, Burke TRJr, Rice KE, Holaday JW. Morphine tolerance increases mu-noncompetitive delta binding sites.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1986;124:113&#8211;119.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(86)90130-5>10.1016/0014-2999(86)90130-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Yukhananov RY, Klodt PM, Riva AD, Zeitsev SV, Masky AI. Opiate withdrawal correlates with the presence of DSLET high-affinity binding.<Emphasis Type="Italic">Pharmacol Biochem Behav</Emphasis>. 1994;49:1109&#8211;1112.</td><td><a href=http://dx.doi.org/10.1016/0091-3057(94)90273-9>10.1016/0091-3057(94)90273-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Kest B, Lee CY, McLemore GL, Inturrisi CE. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice.<Emphasis Type="Italic">Brain Res Bull</Emphasis>. 1996;39:185&#8211;188.</td><td><a href=http://dx.doi.org/10.1016/0361-9230(95)02092-6>10.1016/0361-9230(95)02092-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Zhu Y, King MA, Schuller AG, et al. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knock-out mice.<Emphasis Type="Italic">Neuron</Emphasis>. 1999;24:243&#8211;252.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(00)80836-3>10.1016/S0896-6273(00)80836-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of &#956; and &#948; opiate receptors in enhancing morphine analgesia.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2004;101:5135&#8211;5139.</td><td><a href=http://dx.doi.org/10.1073/pnas.0307601101>10.1073/pnas.0307601101</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Freye E, Latasch L, Portoghese PS. The delta receptor is involved in sufentanil-induced respiratory depression&#8212;opioid subreceptors mediate different effects.<Emphasis Type="Italic">Eur J Anaesthesiol</Emphasis>. 1992;9:457&#8211;462.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Foxx-Orenstein AE, Jin JG, Grider JR. 5TH4 receptor agonists and delta opioid receptor antagonists act synergistically to stimulate colonic propulsion.<Emphasis Type="Italic">Am J Physiol</Emphasis>. 1998;275:G979-G983.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Schiller PW, Nguyen TM-D, Weltrowska G, et al. Differential stereochemical requirements of &#956; vs &#948; opioid receptors for ligand binding and signal transduction: development of a class of potent and highly &#948;-selective peptide antagonists.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:11871&#8211;11875.</td><td><a href=http://dx.doi.org/10.1073/pnas.89.24.11871>10.1073/pnas.89.24.11871</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Schiller PW, Fundytus ME, Merovitz L, et al. The opioid &#956; agonist/&#948; antagonist DIPP-NH<Subscript>2</Subscript>[&#966;] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1999;42:3520&#8211;3526.</td><td><a href=http://dx.doi.org/10.1021/jm980724+>10.1021/jm980724+</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Schiller PW, Weltrowska G, Berezowska I, et al. The TIPP opioid peptide family: development of &#948; antagonists, &#948; agonists and mixed &#956; agonist/&#948; antagonists.<Emphasis Type="Italic">Biopolymers (Peptide Science)</Emphasis>. 1999;51:411&#8211;425.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1097-0282(1999)51:6&lt;411::AID-BIP4&gt;3.0.CO;2-Z>10.1002/(SICI)1097-0282(1999)51:6&lt;411::AID-BIP4&gt;3.0.CO;2-Z</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Weltrowska G, Lemieux C, Chung NN, Schiller PW. A chimeric opioid peptide with mixed &#956; agonist/&#948; antagonist properties.<Emphasis Type="Italic">J Pept Res</Emphasis>. 2004;63:63&#8211;68.</td><td><a href=http://dx.doi.org/10.1111/j.1399-3011.2003.00108.x>10.1111/j.1399-3011.2003.00108.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Ananthan S, Kezar HS III, Carter RL, et al. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido-and pyrimidomorphinans.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1999;42: 3527&#8211;3538.</td><td><a href=http://dx.doi.org/10.1021/jm990039i>10.1021/jm990039i</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Ananthan S, Khare NK, Saini SK, et al. Identification of opioid ligands possessing mixed &#956; agonist/&#948; antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2004;47:1400&#8211;1412.</td><td><a href=http://dx.doi.org/10.1021/jm030311v>10.1021/jm030311v</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>